首页> 外文期刊>Nephron >beta(2)-Microglobulin Clearance Decreases with Renalin Reuse.
【24h】

beta(2)-Microglobulin Clearance Decreases with Renalin Reuse.

机译:β(2)-微球蛋白清除率随肾素的重复使用而降低。

获取原文
获取原文并翻译 | 示例
           

摘要

The HEMO study revealed that beta(2)-microglobulin clearance decreases over time with Renalin reuse in the high-flux group. It was suggested that the reuse of polysulfone or cellulose triacetate high-flux dialyzers with Renalin (without bleach) results in degradation of the high-flux capacity. At our haemodialysis unit (Vila Real, Portugal) we reused dialyzers until January 2000 (limited to 10 reuses), with an automatic machine Renatron(reg) (Renal Systems, Minntech(reg)). All of our 31 patients who started with postdilution haemodiafiltration on-line (HDFol) were always dialyzed with F-80 polysulfone (Fresenius(reg)). The reposition rate was 10 litres/session until 1998 and 20 litres/session thereafter. Reuse techniques were abandoned in our country in January 2000 following an EEC directive. Thereafter, we have decided to maintain HDFol with the same dialyzers without reuse. The mean beta(2)-microglobulin predialysis values did not decrease over time until reuse was terminated (1995 with low-flux haemodialysis: 25.4 plus minus 6.4 mug/l; 1997: 24.7 plus minus 6.6 mug/l; 1998: 29.2 plus minus 8.9 mug/l; 1999: 33.7 plus minus 4.7 mug/l) whereas beta(2)-microglobulin clearances were reasonable with HDFol (1998: 56.4 plus minus 25.9 ml/min; 1999: 47.9 plus minus 16.4 ml/min). After stopping reuse we have noticed that predialysis beta(2)-microglobulin values decreased (2000: 23.0 plus minus 3.9 mug/l) in accordance with beta(2)-microglobulin clearance duplication (2000: 84.1 plus minus 25.0 ml/min; p < 0.01). It is our opinion that the reuse of polysulfone dialyzers with Renalin should be abandoned in the field of high-flux haemodialysis. It causes deterioration in the beta(2)-microglobulin clearance and probably interferes with the high-flux haemodialysis benefits, namely the reduction of dialysis-related amyloidosis.
机译:HEMO研究表明,高通量组中,随着肾素的重复使用,β(2)-微球蛋白清除率随时间降低。有人建议将聚砜或三醋酸纤维素高通量透析器与肾上腺素(不使用漂白剂)重复使用会导致高通量能力下降。在我们的血液透析部门(葡萄牙Vila Real),我们使用自动机器Renatron(reg)(Renal Systems,Minntech(reg))重复使用透析器,直到2000年1月(限制重复使用10次)。我们所有31名开始进行稀释后血液透析滤过在线(HDFol)的患者都始终用F-80聚砜(Fresenius(reg))进行透析。 1998年之前的重新安置率为10升/节,此后为20升/节。遵循EEC指令,我国在2000年1月放弃了重复使用技术。此后,我们决定使用相同的透析器维护HDFol,而不重复使用。在终止再使用之前,平均β(2)-微球蛋白透析前值不会随时间降低(1995年低通量血液透析:25.4加负6.4杯/升; 1997:24.7加负6.6杯/升; 1998:29.2加负8.9杯/升; 1999年:33.7负4.7杯/升),而HDFol的β(2)-微球蛋白清除率是合理的(1998:56.4负25.9毫升/分钟; 1999:47.9负16.4毫升/分钟)。停止重复使用后,我们注意到透析前的β(2)-微球蛋白值降低(2000:23.0 + 3.9杯/升),与β(2)-微球蛋白清除重复(2000:84.1 +负25.0 ml / min; p <0.01)。我们认为,在高通量血液透析领域,应放弃将多砜透析器与肾上腺素一起重复使用。它会导致β(2)-微球蛋白清除率下降,并可能干扰高通量血液透析的益处,即减少与透析有关的淀粉样变性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号